المؤلفون: L. Krylova V., D. Khasanova R., N. Agafonova V., Л. Крылова В., Д. Хасанова Р., Н. Агафонова В.

المصدر: Meditsinskiy sovet = Medical Council; № 10 (2021); 101-107 ; Медицинский Совет; № 10 (2021); 101-107 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: spasticity, focal brain damage, botulinum toxin, rehabilitation, pathological movement pattern, upper limb, lower limb, спастичность, очаговое поражение головного мозга, ботулотоксин, реабилитация, патологический двигательный паттерн, верхняя конечность, нижняя конечность

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/6270/5684; Doan O.V., Brashear A., GiLLard PJ., Varon S.F., Vandenburgh A.M., TurkeL C.C., ELovic E.P Relationship between Disability and HeaLth-ReLated Quality of Life and Caregiver Burden in Patients with Upper Limb Poststroke Spasticity. PM R. 2012;4(1):4-10. https://doi.org/10.1016/j.pmrj.2011.10.001.; Martin A., Abogunrin S., Kurth H., Dinet J. EpidemioLogicaL, Humanistic, and Economic Burden of ILLness of Lower Limb Spasticity in AduLts: A Systematic Review. Neuropsychiatr Dis Treat. 2014;10:111-122. https://doi.org/10.2147/NDT.S53913.; Hobart J.C., Riazi A., Thompson AJ., StyLes I.M., Ingram W., Vickery PJ. et aL. Getting the Measure of Spasticity in MuLtipLe ScLerosis: the MuLtipLe ScLerosis Spasticity ScaLe (MSSS-88).Brain. 2006;129(Pt 1):224-234. https://doi.org/10.1093/brain/awh675.; WisseL J., Manack A., Brainin M. Toward an EpidemioLogy of Poststroke Spasticity. Neurology. 2013;80(3 SuppL 2):S13-S19. https://doi.org/10.1212/WNL.0b013e3182762448.; Zorowitz R.D., GiLLard PJ., Brainin M. Poststroke Spasticity: SequeLae and Burden on Stroke Survivors and Caregivers. Neurology. 2013;80(3 SuppL 2): S45-S52. https://doi.org/10.1212/WNL.0b013e3182764c86.; Rizzo M.A., HadjimichaeL O.C., Preiningerova J., VoLLmer T.L. PrevaLence and Treatment of Spasticity Reported by MuLtipLe ScLerosis Patients. Mult Scler. 2004;10(5):589-595. https://doi.org/10.1191/1352458504ms1085oa.; Buhse M. Assessment of Caregiver Burden in FamiLies of Persons with MuLtipLe ScLerosis. J Neurosci Nurs. 2008;40(1):25-31. https://doi.org/10.1097/01376517-200802000-00005.; Adams M.M., Hicks A.L. Spasticity after SpinaL Cord Injury. Spinal Cord. 2005;43(10):577-586. https://doi.org/10.1038/sj.sc.3101757.; Pandyan A.D., Gregoric M., Barnes M.P., Wood D., Van Wijck F., Burridge J. et aL. Spasticity: CLinicaL Perceptions, NeuroLogicaL ReaLities and MeaningfuL Measurement. Disabil Rehabil. 2005;27(1-2):2-6. https://doi.org/10.1080/09638280400014576.; Kheder A., Nair K.P. Spasticity: PathophysioLogy, EvaLuation and Management. Pract Neurol. 2012;12(5):289-298. https://doi.org/10.1136/practneuroL-2011-000155.; Mayer N.H., Esquenazi A. MuscLe Overactivity and Movement Dysfunction in the Upper Motoneuron Syndrome. Phys Med Rehabil Clin N Am. 2003;14(4):855-883. https://doi.org/10.1016/s1047-9651(03)00093-7.; Thompson AJ., Jarrett L., LockLey L., Marsden J., Stevenson V.L. CLinicaL Management of Spasticity. J Neurol Neurosurg Psychiatry. 2005;76(4):459-463. https://doi.org/10.1136/jnnp.2004.035972.; Бойко А.Н., Лащ Н.Ю., Батышева Т.Т. Повышение мышечного тонуса: этиология, патогенез, коррекция. Справочник поликлинического врача. 2004;(1):28-30. Режим доступа: https://eLibrary.ru/item.asp?id=26687715&.; Trompetto C., Marinelli L., Mori L., Pelosin E., Curra A., Molfetta L., Abbruzzese G. Pathophysiology of Spasticity: Implications for Neurorehabilitation. Biomed Res Int. 2014;354906. https://doi.org/10.1155/2014/354906.; Mukherjee A., Chakravarty A. Spasticity Mechanisms - for the Clinician. Front Neurol. 2010;1:149. https://doi.org/10.3389/fneur.2010.00149.; Gracies J.M. Pathophysiology of Spastic Paresis. I: Paresis and Soft Tissue Changes. Muscle Neve. 2005;31(5):535-551. https://doi.org/10.1002/mus.20284.; De Bruin M., Smeulders MJ., Kreulen M., Huijing P.A., Jaspers R.T. Intramuscular Connective Tissue Differences in Spastic and Control Muscle: A Mechanical and Histological Study. PLoS One. 2014;9(6):e101038. https://doi.org/10.1371/journal.pone.0101038.; Simpson D.M., Patel A.T., Alfaro A., Ayyoub Z., Charles D., Dashtipour K. et al. OnabotulinumtoxinA Injection for Poststroke Upper-Limb Spasticity: Guidance for Early Injectors From a Delphi Panel Process. PM R. 2017;9(2):136-148. https://doi.org/10.1016/j.pmrj.2016.06.016.; Esquenazi A., Alfaro A., Ayyoub Z., Charles D., Dashtipour K., Graham G.D. et al. OnabotulinumtoxinA for Lower Limb Spasticity: Guidance From a Delphi Panel Approach. PM R. 2017;9(10):960-968. https://doi.org/10.1016/j.pmrj.2017.02.014.; Yelnik A.P., Simon O., Parratte B., Gracies J.M. How to Clinically Assess and Treat Muscle Overactivity in Spastic Paresis. J Rehabil Med. 2010;42(9): 801-807. https://doi.org/10.2340/16501977-0613.; Ashworth B. Preliminary Trial of Carisoprodol in Multiple Sclerosis. Practitioner. 1964;192:540-542. Available at: https://pubmed.ncbi.nlm.nih.gov/14143329/.; Bohannon R.W., Smith M.B. Interrater Reliability of a Modified Ashworth Scale of Muscle Spasticity. Phys Ther. 1987;67(2):206-207. https://doi.org/10.1093/ptj/67.2.206.; Tardieu G., Shentoub S., Delarue R. Research on a Technic for Measurement of Spasticity. Rev Neurol (Paris). 1954;91(2):143-144. (In French) Available at: https://pubmed.ncbi.nlm.nih.gov/14358132/.; Morris S. Ashworth and Tardieu Scale: Their Clinical Relevance for Measuring Spasticity in Adult and Pediatric Neurological Populations. Phys Ther Rev. 2002;7(1):53-62. https://doi.org/10.1179/108331902125001770.; Haugh A.B., Pandyan A.D., Johnson G.R. A Systematic Review of the Tardieu Scale for the Measurement of Spasticity. Disabil Rehabil. 2006;28(15):899-907. https://doi.org/10.1080/09638280500404305.; Scott J., Huskisson EC. Graphic Representation of Pain. Pain. 1976;2(2):175-184. Available at: https://pubmed.ncbi.nlm.nih.gov/1026900/.; Ozcakir S., Sivrioglu K. Botulinum Toxin in Poststroke Spasticity. Clin Med Res. 2007;5(2):132-138. https://doi.org/10.3121/cmr.2007.716.; Van Swieten J.C., Koudstaal PJ., Visser M.C., Schouten HJ., van Gijn J. Interobserver Agreement for the Assessment of Handicap in Stroke Patients. Stroke. 1988;19(5):604-607. https://doi.org/10.1161/01.str.19.5.604.; Oxford Grice K., Vogel K.A., Le V., Mitchell A., Muniz S., Vollmer M.A. Adult Norms for a Commercially Available Nine Hole Peg Test for Finger Dexterity. Am J Occup Ther. 2003;57(5):570-573. https://doi.org/10.5014/ajot.57.5.570.; Wallace J.D. Summary of Combined Clinical Analysis of Controlled Clinical Trials with Tizanidine. Neurology. 1994;44(11 Suppl 9):S60-S68. Available at: https://pubmed.ncbi.nlm.nih.gov/7970013/.; Gracies J.M., Esquenazi A., Brashear A., Banach M., Kocer S., Jech R. et al. Efficacy and Safety of AbobotulinumtoxinA in Spastic Lower Limb: Randomized Trial and Extension. Neurology. 2017;89(22):2245-2253. https://doi.org/10.1212/WNL.0000000000004687.; Turner-Stokes L., Baguley IJ., De Graaff S., Katrak P., Davies L., McCrory P., Hughes A. Goal Attainment Scaling in the Evaluation of Treatment of Upper Limb Spasticity with Botulinum Toxin: A Secondary Analysis from a DoubleBlind Placebo-Controlled Randomized Clinical Trial. J Rehabil Med. 2010;42(1):81-89. https://doi.org/10.2340/16501977-0474.; Одинак М.М., Литвиненко И.В. (ред.). Нервные болезни. СПб.: СпецЛит; 2020. 575 с. Режим доступа: https://speclit.su/image/cata-log/978-5-299-01025-1/978-5-299-01025-1.pdf.; Yelnik A.P, Simon O., Parratte B., Gracies J.M. How to Clinically Assess and Treat Muscle Overactivity in Spastic Paresis. J Rehabil Med. 2010;42(9):801-807. https://doi.org/10.2340/16501977-0613.; Lindsay C., Kouzouna A., Simcox C., Pandyan A.D. Pharmacological Interventions Other Than Botulinum Toxin for Spasticity after Stroke. Cochrane Database Syst Rev. 2016;10(10):CD010362. Available at: https://pubmed.ncbi.nlm.nih.gov/27711973/.; Laxe S. Which Interventions Are Useful for Managing Muscle Spasticity in Individuals Who Sustained Traumatic Brain Injury? - A Cochrane Review Summary with Commentary. NeuroRehabilitation. 2019;44(1):157-159. https://doi.org/10.3233/NRE-189003.; Harris J.E., Eng JJ. Strength Training Improves Upper-Limb Function in Individuals with Stroke: A Meta-Analysis. Stroke. 2010;41(1):136-140. https://doi.org/10.1161/STROKEAHA.109.567438.; Lin S., Sun Q., Wang H., Xie G. Influence of Transcutaneous Electrical Nerve Stimulation on Spasticity, Balance, and Walking Speed in Stroke Patients: A Systematic Review and Meta-Analysis. J Rehabil Med. 2018;50(1):3-7. https://doi.org/10.2340/16501977-2266.; Mahmood A., Veluswamy S.K., Hombali A., Mullick A., N M., Solomon J.M. Effect of Transcutaneous Electrical Nerve Stimulation on Spasticity in Adults with Stroke: A Systematic Review and Meta-analysis. Arch Phys Med Rehabil. 2019;100(4):751-768. https://doi.org/10.1016/j.apmr.2018.10.016.; Xiang J., Wang W., Jiang W., Qian Q. Effects of Extracorporeal Shock Wave Therapy on Spasticity in Post-Stroke Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Rehabil Med. 2018;50(10):852-859. https://doi.org/10.2340/16501977-2385.; McIntyre A., Mirkowski M., Thompson S., Burhan A.M., Miller T., Teasell R. A Systematic Review and Meta-Analysis on the Use of Repetitive Transcranial Magnetic Stimulation for Spasticity Poststroke. PM R. 2018;10(3):293-302. https://doi.org/10.1016/j.pmrj.2017.10.001.; Cai Y., Zhang C.S., Liu S., Wen Z., Zhang A.L., Guo X. et al. Electroacupuncture for Poststroke Spasticity: A Systematic Review and Meta-Analysis. Arch Phys Med Rehabil. 2017;98(12):2578.e4-2589.e4. https://doi.org/10.1016/j.apmr.2017.03.023.; Salazar A.P., Pinto C., Ruschel Mossi J.V., Figueiro B., Lukrafka J.L., Pagnussat A.S. Effectiveness of Static Stretching Positioning on PostStroke Upper-Limb Spasticity and Mobility: Systematic Review with MetaAnalysis. Ann Phys Rehabil Med. 2019;62(4):274-282. https://doi.org/10.1016/j.rehab.2018.11.004.; Austrian Guideline of Neurorehabilitation after Stroke. Neurologisch. 2018;3S. Available at: https://www.xn-gsf-rna.at/wp-content/uploads/2016/11/Positionspapier-2018_OEGSF_neurologisch.pdf.; Dolly J.O., Aoki K.R. The Structure and Mode of Action of Different Botulinum Toxins. Eur J Neurol. 2006;13(Suppl 4):1-9. https://doi.org/10.1111/j.1468-1331.2006.01648.x; Park J., Chung M.E. Botulinum Toxin for Central Neuropathic Pain. Toxins (Basel). 2018;10(6):224. https://doi.org/10.3390/toxins10060224.; Park J., Park HJ. Botulinum Toxin for the Treatment of Neuropathic Pain. Toxins (Basel). 2017;9(9):260. https://doi.org/10.3390/toxins9090260.; Li S. Spasticity, Motor Recovery, and Neural Plasticity after Stroke. Front Neurol. 2017;8:120. https://doi.org/10.3389/fneur.2017.00120.; Turkel C.C., Bowen B., Liu J., Brin M.F. Pooled Analysis of the Safety of Botulinum Toxin Type A in the Treatment of Poststroke Spasticity. Arch Phys Med Rehabil. 2006;87(6):786-792. https://doi.org/10.1016/j.apmr.2006.02.015.; Jia S., Liu Y., Shen L., Liang X., Xu X., Wei Y. Botulinum Toxin Type A for Upper Limb Spasticity in Poststroke Patients: A Meta-analysis of Randomized Controlled Trials. J Stroke Cerebrovasc Dis. 2020;29(6):104682. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104682.; Olver J., Esquenazi A., Fung V.S., Singer BJ., Ward A.B. Botulinum Toxin Assessment, Intervention and Aftercare for Lower Limb Disorders of Movement and Muscle Tone in Adults: International Consensus Statement. Eur J Neurol. 2010;17(2 Suppl.):57-73. https://doi.org/10.1111/j.1468-1331.2010.03128.x.; Gupta A.D., Chu W.H., Howell S., Chakraborty S., Koblar S., Visvanathan R. et al. A Systematic Review: Efficacy of Botulinum Toxin in Walking and Quality of Life in Post-Stroke Lower Limb Spasticity. Syst Rev. 2018;7(1):1. https://doi.org/10.1186/s13643-017-0670-9.; Sun L.C., Chen R., Fu C., Chen Y., Wu Q., Chen R. et al. Efficacy and Safety of Botulinum Toxin Type A for Limb Spasticity after Stroke: A Meta-Analysis of Randomized Controlled Trials. Biomed Res Int. 2019:8329306 https://doi.org/10.1155/2019/8329306.; Rosales R.L., Kong K.H., Goh K.J., Kumthornthip W., Mok V.C., Delgado-De Los Santos M.M. et al. Botulinum Toxin Injection for Hypertonicity of the Upper Extremity within 12 Weeks after Stroke: A Randomized Controlled Trial. Neurorehabil Neural Repair. 2012;26(7):812-821. https://doi.org/10.1177/1545968311430824.; Rosales R.L., Efendy F., Teleg E.S., Delos Santos M.M., Rosales M.C., Ostrea M. et al. Botulinum Toxin as Early Intervention for Spasticity after Stroke or Non-Progressive Brain Lesion: A Meta-Analysis. J Neurol Sci. 2016;371:6-14. https://doi.org/10.1016/j.jns.2016.10.005.; Tao W., Yan D., Li J.H., Shi Z.H. Gait Improvement by Low-Dose Botulinum Toxin A Injection Treatment of the Lower Limbs in Subacute Stroke Patients. J Phys Ther Sci. 2015;27(3):759-762. https://doi.org/10.1589/jpts.27.759.; Gracies J.M., O’Dell M., Vecchio M., Hedera P, Kocer S., Rudzinska-Bar M. et al. Effects of Repeated AbobotulinumtoxinA Injections in Upper Limb Spasticity. Muscle Nerve. 2018;57(2):245-254. https://doi.org/10.1002/mus.25721.; Mills P.B., Finlayson H., Sudol M., O’Connor R. Systematic Review of Adjunct Therapies to Improve Outcomes Following Botulinum Toxin Injection for Treatment of Limb Spasticity. Clin Rehabil. 2016;30(6):537-548. https://doi.org/10.1177/0269215515593783.; https://www.med-sovet.pro/jour/article/view/6270

الاتاحة: https://www.med-sovet.pro/jour/article/view/6270
https://doi.org/10.21518/2079-701X-2021-10-101-107